1991Journal of Fish DiseasesRequires access

Fluoroquinolones display rapid bactericidal activity and low mutation frequencies against Aeromonas salmonicida

Andrew C. Barnes, S. G. B. Amyes, T. S. Hastings, C. S. Lewin

Open publisher page 19 citations

Abstract

Abstract. Oxolinic acid and five new fluoroquinolones, sarafloxacin, enrofloxacin, PD127, 391, PD117, 596 and C1934, were evaluated for in vitro activity against Aeromonas salmonicida. Sarafloxacin, enrofloxacin, PD127, 391 and PD117, 596 were significantly more active than cither oxolinic acid or C1934 in terms of their bactericidal activity against both oxolinic‐acid‐resistant and sensitive strains of A. salmonicida, killing 99% of the bacteria after 1h exposure. Resistant mutants developed at lower frequency to the fluoroquinolones than to oxolinic acid or oxytctracycline at 5, 10 and 20 times the MIC. However, mutants selected with one quinolone were cross‐resistant to all the other quinolones tested.

About this research paper

What this paper is about

Abstract. Oxolinic acid and five new fluoroquinolones, sarafloxacin, enrofloxacin, PD127, 391, PD117, 596 and C1934, were evaluated for in vitro activity against Aeromonas salmonicida. Sarafloxacin, enrofloxacin, PD127, 391 and PD117, 596 were significantly more active than cither oxolinic acid or C1934 in terms of their bactericidal activity against both oxolinic‐acid‐resistant and sensitive strains of A. salmonicida, killing 99% of the bacteria after 1h exposure. Resistant mutants developed at lower frequency to the fluoroquinolones than to oxolinic acid or oxytctracycline at 5, 10 and 20 times the MIC. However, mutants selected with one quinolone were cross‐resistant to all the other quinolones tested.

Why it matters

OpenAlex reports 19 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract. Oxolinic acid and five new fluoroquinolones, sarafloxacin, enrofloxacin, PD127, 391, PD117, 596 and C1934, were evaluated for in vitro activity against Aeromonas salmonicida. Sarafloxacin, enrofloxacin, PD127, 391 and PD117, 596 were significantly more active than cither oxolinic acid or C1934 in terms of their bactericidal activity against both oxolinic‐acid‐resistant and sensitive strains of A. salmonicida, killing 99% of the bacteria after 1h exposure. Resistant mutants developed at lower frequency to the fluoroquinolones than to oxolinic acid or oxytctracycline at 5, 10 and 20 times the MIC. However, mutants selected with one quinolone were cross‐resistant to all the other quinolones tested.

Key concepts: Oxolinic acid, Enrofloxacin, Aeromonas salmonicida, Microbiology, Biology, Quinolone, Aeromonas hydrophila, Antibiotics

Related papers

Back to paper searchBrowse research topicsOriginal source
Fluoroquinolones display rapid bactericidal activity and low mutation frequencies against Aeromonas salmonicida — Research Paper | ScholarLens